Literature DB >> 5023910

Vagotomy and pyloroplasty for gastric ulcer.

R J Clarke, D L Lewis, J A Williams.   

Abstract

In a series of 68 patients with gastric ulcer who were treated by vagotomy and pyloroplasty there were no operative deaths, though one patient who received massive transfusions died 14 weeks later from hepatic necrosis probably associated with serum hepatitis. Four patients developed recurrent peptic ulceration requiring further surgical treatment. The clinical condition of all but three of the remainder was satisfactory after an average follow-up period of three years and two months. Of the 14 patients who presented with an acutely bleeding gastric ulcer, one subsequently required gastrectomy for continued bleeding; in all the others the immediate and long-term results were satisfactory. Of 21 patients with a "high" ulcer and 29 with combined gastric and duodenal ulceration one (4.8%) and three (10%) respectively suffered recurrences. We conclude that vagotomy and pyloroplasty is a satisfactory form of treatment for a high or bleeding gastric ulcer, but that for all other gastric ulcers some form of gastric resection is preferable.

Entities:  

Mesh:

Year:  1972        PMID: 5023910      PMCID: PMC1788223          DOI: 10.1136/bmj.2.5810.369

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  GASTRIC ULCER AND CONSERVATIVE SURGERY: VAGUS RESECTION AND FINNEY'S PYLOROPLASTY.

Authors:  W G HENDRY; Z A BAHRANI
Journal:  Br J Surg       Date:  1965-08       Impact factor: 6.939

2.  The special significance of concomitant gastric and duodenal ulcers.

Authors:  H D JOHNSON
Journal:  Lancet       Date:  1955-02-05       Impact factor: 79.321

3.  Vagotomy for gastric ulcer combined with duodenal ulcer.

Authors:  M C Douglas; H L Duthie
Journal:  Br J Surg       Date:  1971-10       Impact factor: 6.939

4.  Four-year to eight-year results of vagotomy and simple drainage for benign lesser curve gastric ulcer.

Authors:  H Burge; A M Gill; C Maclean; R Stedeford
Journal:  Br Med J       Date:  1970-08-15

Review 5.  Factors in the pathogenesis of gastric ulcer. Hunterian lecture delivered at the Royal College of Surgeons of England on 18th January 1966.

Authors:  W M Capper
Journal:  Ann R Coll Surg Engl       Date:  1967-01       Impact factor: 1.891

6.  Surgical treatment of gastric ulcers. Controlled comparison of Billroth-I gastrectomy and vagotomy and pyloroplasty.

Authors:  H L Duthie; T H Moore; D Bardsley; R G Clark
Journal:  Br J Surg       Date:  1970-10       Impact factor: 6.939

7.  Clinical trial of vagotomy and pyloroplasty in the treatment of benign gastric ulcer.

Authors:  J L Sawyers; H W Scott; C Graham
Journal:  Am J Surg       Date:  1971-02       Impact factor: 2.565

8.  Vagotomy and the gastric ulcer.

Authors:  R O Kraft; J Myers; S Overton; W J Fry
Journal:  Am J Surg       Date:  1971-02       Impact factor: 2.565

9.  The aetiology of benign lesser curve gastric ulcer: vagotomy and pyloroplasty in its treatment.

Authors:  H Burge
Journal:  Ann R Coll Surg Engl       Date:  1966-06       Impact factor: 1.891

10.  Some other operations for gastric ulcer. A. Kelling-Madlener operation. B. Wedge resection and pyloroplasty. C. Pyloroplasty (with ulcer in situ).

Authors:  J M Farris; G K Smith
Journal:  Surg Clin North Am       Date:  1966-04       Impact factor: 2.741

View more
  4 in total

1.  [Complications of the vagotomy during the operation and in the early postoperative period (author's transl)].

Authors:  M Ihász; M Réfi; L Kiss
Journal:  Langenbecks Arch Chir       Date:  1976-07-23

2.  High gastric ulcer.

Authors:  H E Jensen; J Hoffmann; P Wille-Jørgensen
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

Review 3.  Annual review of surgery 1972.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1973-09       Impact factor: 2.401

4.  Vagotomy or gastrectomy for elective treatment of benign gastric ulceration?

Authors:  M J Greenall; T Lehnert
Journal:  Dig Dis Sci       Date:  1985-04       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.